Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 217-230

  Sheahan, Timothy ^a,c   Whitmore, Alan ^b   Long, Kristin ^b   Ferris, Martin ^b   Rockx, Barry ^c,d   Funkhouser, William ^a   Donaldson, Eric ^c   Gralinski, Lisa ^c   Collier, Martha ^b   Heise, Mark ^a,b   Davis, Nancy ^a,b   Johnston, Robert ^a,b   Baric, Ralph S ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INFLUENZA VACCINE; LIVE VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VEE VIRUS REPLICON PARTICLE GLYCOPROTEIN[3000]; VEE VIRUS REPLICON PARTICLE GLYCOPROTEIN[3014]; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; IMMUNITY; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INNATE IMMUNITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARS CORONAVIRUS; SENESCENCE; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINE FAILURE; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ATTENUATION; VIRUS PARTICLE; VIRUS STRAIN; WILD TYPE;

AGING; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; FEMALE; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; REPLICON; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRION;

ANIMALIA; MUS; NOROVIRUS; ORTHOMYXOVIRIDAE; SARS CORONAVIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; WEST NILE VIRUS;

EID: 78650059561     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01805-10     Document Type: Article

References (70)

1. Anonymous. 1995. From the Centers for Disease Control and Prevention. Pneumonia and influenza death rates - United States, 1979-1994. JAMA 274:532.
2. Anonymous. 2009. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58:521-524.
3. Asanuma, H., K. Hirokawa, M. Uchiyama, Y. Suzuki, C. Aizawa, T. Kurata, T. Sata, and S. Tamura. 2001. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine 19:3981-3989. (Pubitemid 32566323)
4. Baric, R. S., T. Sheahan, D. Deming, E. Donaldson, B. Yount, A. C. Sims, R. S. Roberts, M. Frieman, and B. Rockx. 2006. SARS coronavirus vaccine development. Adv. Exp. Med. Biol. 581:553-560.
5. Bender, B. S., S. F. Taylor, D. S. Zander, and R. Cottey. 1995. Pulmonary immune response of young and aged mice after influenza challenge. J. Lab. Clin. Med. 126:169-177.
6. Ben-Yehuda, A., D. Ehleiter, A. R. Hu, and M. E. Weksler. 1993. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection. J. Infect. Dis. 168:352-357.
7. Bernard, K. A., W. B. Klimstra, and R. E. Johnston. 2000. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276:93-103.
8. Bernstein, D. I., E. A. Reap, K. Katen, A. Watson, K. Smith, P. Norberg, R. A. Olmsted, A. Hoeper, J. Morris, S. Negri, M. F. Maughan, and J. D. Chulay. 2009. Randomized, double-blind, phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28:484-493.
9. Bernstein, E., D. Kaye, E. Abrutyn, P. Gross, M. Dorfman, and D. M. Murasko. 1999. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17:82-94.
10. Bernstein, E. D., E. M. Gardner, E. Abrutyn, P. Gross, and D. M. Murasko. 1998. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 16:1722-1731.
11. Bisht, H., A. Roberts, L. Vogel, A. Bukreyev, P. L. Collins, B. R. Murphy, K. Subbarao, and B. Moss. 2004. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc. Natl. Acad. Sci. U. S. A. 101:6641-6646.
12. Booth, C. M., L. M. Matukas, G. A. Tomlinson, A. R. Rachlis, D. B. Rose, H. A. Dwosh, S. L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I. E. Ephtimios, I. Kitai, B. D. Mederski, S. B. Shadowitz, W. L. Gold, L. A. Hawryluck, E. Rea, J. S. Chenkin, D. W. Cescon, S. M. Poutanen, and A. S. Detsky. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289:2801-2809.
13. Chinese, S. M. E. C. 2004. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303:1666-1669.
14. Davis, N. L., N. Powell, G. F. Greenwald, L. V. Willis, B. J. Johnson, J. F. Smith, and R. E. Johnston. 1991. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology 183:20-31.
15. Deming, D., T. Sheahan, M. Heise, B. Yount, N. Davis, A. Sims, M. Suthar, J. Harkema, A. Whitmore, R. Pickles, A. West, E. Donaldson, K. Curtis, R. Johnston, and R. Baric. 2006. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med. 3:e525.
16. Donnelly, C. A., A. C. Ghani, G. M. Leung, A. J. Hedley, C. Fraser, S. Riley, L. J. Abu-Raddad, L. M. Ho, T. Q. Thach, P. Chau, K. P. Chan, T. H. Lam, L. Y. Tse, T. Tsang, S. H. Liu, J. H. Kong, E. M. Lau, N. M. Ferguson, and R. M. Anderson. 2003. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361:1761-1766.
17. Du, L., G. Zhao, Y. He, Y. Guo, B. J. Zheng, S. Jiang, and Y. Zhou. 2007. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine 25:2832-2838. (Pubitemid 46412568)
18. Du, L., G. Zhao, Y. Lin, C. Chan, Y. He, S. Jiang, C. Wu, D. Y. Jin, K. Y. Yuen, Y. Zhou, and B. J. Zheng. 2008. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARSCoV infection. Vaccine 26:1644-1651.
19. Eaton, S. M., E. M. Burns, K. Kusser, T. D. Randall, and L. Haynes. 2004. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J. Exp. Med. 200:1613-1622.
20. Edelson, B. T., and E. R. Unanue. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869-3875.
21. Effros, R. B. 2007. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25:599-604.
22. Fluet, M. E., A. C. Whitmore, D. A. Moshkoff, K. Fu, Y. Tang, M. L. Collier, A. West, D. T. Moore, R. Swanstrom, R. E. Johnston, and N. L. Davis. 2008. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine. Virology 370:22-32.
23. Frieman, M. B., J. Chen, T. E. Morrison, A. Whitmore, W. Funkhouser, J. M. Ward, E. W. Lamirande, A. Roberts, M. Heise, K. Subbarao, and R. S. Baric. 2010. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog. 6:e1000849.
24. Fujihashi, K., T. Koga, and J. R. McGhee. 2000. Mucosal vaccination and immune responses in the elderly. Vaccine 18:1675-1680.
25. Goodwin, K., C. Viboud, and L. Simonsen. 2006. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24:1159-1169. (Pubitemid 43202262)
26. Goronzy, J. J., J. W. Fulbright, C. S. Crowson, G. A. Poland, W. M. O'Fallon, and C. M. Weyand. 2001. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 75: 12182-12187.
27. Gruver, A. L., L. L. Hudson, and G. D. Sempowski. 2007. Immunosenescence of ageing. J. Pathol. 211:144-156.
28. Guan, Y., B. J. Zheng, Y. Q. He, X. L. Liu, Z. X. Zhuang, C. L. Cheung, S. W. Luo, P. H. Li, L. J. Zhang, Y. J. Guan, K. M. Butt, K. L. Wong, K. W. Chan, W. Lim, K. F. Shortridge, K. Y. Yuen, J. S. Peiris, and L. L. Poon. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302:276-278.
29. Han, Y., H. Geng, W. Feng, X. Tang, A. Ou, Y. Lao, Y. Xu, H. Lin, H. Liu, and Y. Li. 2003. A follow-up study of 69 discharged SARS patients. J. Tradit. Chin. Med. 23:214-217.
30. Hancock, K., V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, T. L. Brammer, N. J. Cox, T. M. Tumpey, and J. M. Katz. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
31. Haynes, L., and S. L. Swain. 2006. Why aging T cells fail: implications for vaccination. Immunity 24:663-666.
32. Hu, M. C., T. Jones, R. T. Kenney, D. L. Barnard, D. S. Burt, and G. H. Lowell. 2007. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice. Vaccine 25:6334-6340.
33. Lau, S. K., P. C. Woo, K. S. Li, Y. Huang, H. W. Tsoi, B. H. Wong, S. S. Wong, S. Y. Leung, K. H. Chan, and K. Y. Yuen. 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U. S. A. 102:14040-14045.
34. Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G. M. Joynt, A. Ahuja, M. Y. Yung, C. B. Leung, K. F. To, S. F. Lui, C. C. Szeto, S. Chung, and J. J. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:1986-1994.
35. Leung, G. M., A. J. Hedley, L. M. Ho, P. Chau, I. O. Wong, T. Q. Thach, A. C. Ghani, C. A. Donnelly, C. Fraser, S. Riley, N. M. Ferguson, R. M. Anderson, T. Tsang, P. Y. Leung, V. Wong, J. C. Chan, E. Tsui, S. V. Lo, and T. H. Lam. 2004. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann. Intern. Med. 141:662-673.
36. Liang, W., Z. Zhu, J. Guo, Z. Liu, W. Zhou, D. P. Chin, and A. Schuchat. 2004. Severe acute respiratory syndrome, Beijing, 2003. Emerg. Infect. Dis. 10:25-31.
37. LoBue, A. D., L. Lindesmith, B. Yount, P. R. Harrington, J. M. Thompson, R. E. Johnston, C. L. Moe, and R. S. Baric. 2006. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24:5220-5234.
38. MacDonald, G. H., and R. E. Johnston. 2000. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74:914-922.
39. McElhaney, J. E., J. W. Hooton, N. Hooton, and R. C. Bleackley. 2005. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 23:3294-3300.
40. Miller, R. R., III, B. A. Markewitz, R. T. Rolfs, S. M. Brown, K. K. Dascomb, C. K. Grissom, M. D. Friedrichs, J. Mayer, E. L. Hirshberg, J. Conklin, R. Paine III, and N. C. Dean. 2009. Clinical findings and demographic factors associated with intensive care unit admission in Utah due to 2009 novel influenza A (H1N1) infection. Chest 139:752-758.
41. Monto, A. S., and R. J. Whitley. 2008. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin. Infect. Dis. 46:1024-1031.
42. Morens, D. M., G. K. Folkers, and A. S. Fauci. 2004. The challenge of emerging and re-emerging infectious diseases. Nature 430:242-249.
43. Murray, K., S. Baraniuk, M. Resnick, R. Arafat, C. Kilborn, K. Cain, R. Shallenberger, T. L. York, D. Martinez, J. S. Hellums, D. Hellums, M. Malkoff, N. Elgawley, W. McNeely, S. A. Khuwaja, and R. B. Tesh. 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol. Infect. 134:1325-1332.
44. Pawelec, G., and A. Larbi. 2008. Immunity and ageing in man: annual review 2006/2007. Exp. Gerontol. 43:34-38. (Pubitemid 350235153)
45. Peiris, J. S., C. M. Chu, V. C. Cheng, K. S. Chan, I. F. Hung, L. L. Poon, K. I. Law, B. S. Tang, T. Y. Hon, C. S. Chan, K. H. Chan, J. S. Ng, B. J. Zheng, W. L. Ng, R. W. Lai, Y. Guan, and K. Y. Yuen. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-1772.
46. Peiris, J. S., K. Y. Yuen, A. D. Osterhaus, and K. Stohr. 2003. The severe acute respiratory syndrome. N. Engl. J. Med. 349:2431-2441.
47. Pushko, P., M. Parker, G. V. Ludwig, N. L. Davis, R. E. Johnston, and J. F. Smith. 1997. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239:389-401.
48. Rimmelzwaan, G. F., M. Baars, E. C. Claas, and A. D. Osterhaus. 1998. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J. Virol. Methods 74:57-66.
49. Roberts, A., D. Deming, C. D. Paddock, A. Cheng, B. Yount, L. Vogel, B. D. Herman, T. Sheahan, M. Heise, G. L. Genrich, S. R. Zaki, R. Baric, and K. Subbarao. 2007. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 3:e5.
50. Roberts, A., and K. Subbarao. 2006. Animal models for SARS. Adv. Exp. Med. Biol. 581:463-471.
51. Rockx, B., D. Corti, E. Donaldson, T. Sheahan, K. Stadler, A. Lanzavecchia, and R. Baric. 2008. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. J. Virol. 82:3220-3235. (Pubitemid 351429902)
52. Rockx, B., T. Sheahan, E. Donaldson, J. Harkema, A. Sims, M. Heise, R. Pickles, M. Cameron, D. Kelvin, and R. Baric. 2007. Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice. J. Virol. 81:7410-7423.
53. Sheahan, T., D. Deming, E. Donaldson, R. Pickles, and R. Baric. 2006. Resurrection of an "extinct" SARS-CoV isolate GD03 from late 2003. Adv. Exp. Med. Biol. 581:547-550.
54. Sheahan, T., T. E. Morrison, W. Funkhouser, S. Uematsu, S. Akira, R. S. Baric, and M. T. Heise. 2008. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog. 4:e1000240.
55. Sheahan, T., B. Rockx, E. Donaldson, D. Corti, and R. Baric. 2008. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus. J. Virol. 82:8721-8732.
56. Sheahan, T., B. Rockx, E. Donaldson, A. Sims, R. Pickles, D. Corti, and R. Baric. 2008. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J. Virol. 82:2274-2285.
57. Smits, S. L., A. de Lang, J. M. van den Brand, L. M. Leijten, I. W. F. van, M. J. Eijkemans, G. van Amerongen, T. Kuiken, A. C. Andeweg, A. D. Osterhaus, and B. L. Haagmans. 2010. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 6:e1000756.
58. Spruth, M., O. Kistner, H. Savidis-Dacho, E. Hitter, B. Crowe, M. Gerencer, P. Bruhl, L. Grillberger, M. Reiter, C. Tauer, W. Mundt, and P. N. Barrett. 2006. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses. Vaccine 24:652-661.
59. Subbarao, K., J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W. J. Shieh, S. Zaki, and B. Murphy. 2004. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78:3572-3577.
60. Thompson, J. M., A. C. Whitmore, J. L. Konopka, M. L. Collier, E. M. Richmond, N. L. Davis, H. F. Staats, and R. E. Johnston. 2006. Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc. Natl. Acad. Sci. U. S. A. 103:3722-3727.
61. Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. Anderson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186. (Pubitemid 36068705)
62. Vallejo, A. N. 2005. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 205:158-169.
63. Vasto, S., M. Malavolta, and G. Pawelec. 2006. Age and immunity. Immun. Ageing 3:2.
64. Wang, C. Q., K. B. Udupa, H. Xiao, and D. A. Lipschitz. 1995. Effect of age on marrow macrophage number and function. Aging (Milano) 7:379-384.
65. Wei, C. J., J. C. Boyington, P. M. McTamney, W. P. Kong, M. B. Pearce, L. Xu, H. Andersen, S. Rao, T. M. Tumpey, Z. Y. Yang, and G. J. Nabel. 2010. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064.
66. Wen, Z., L. Ye, Y. Gao, L. Pan, K. Dong, Z. Bu, R. W. Compans, and C. Yang. 2009. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res. 84:215-224.
67. Yang, Z. Y., W. P. Kong, Y. Huang, A. Roberts, B. R. Murphy, K. Subbarao, and G. J. Nabel. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428:561-564.
68. Yount, B., K. M. Curtis, E. A. Fritz, L. E. Hensley, P. B. Jahrling, E. Prentice, M. R. Denison, T. W. Geisbert, and R. S. Baric. 2003. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U. S. A. 100:12995-13000.
69. Yount, B., R. S. Roberts, A. C. Sims, D. Deming, M. B. Frieman, J. Sparks, M. R. Denison, N. Davis, and R. S. Baric. 2005. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J. Virol. 79:14909-14922.
70. Yu, H., Z. Gao, Z. Feng, Y. Shu, N. Xiang, L. Zhou, Y. Huai, L. Feng, Z. Peng, Z. Li, C. Xu, J. Li, C. Hu, Q. Li, X. Xu, X. Liu, Z. Liu, L. Xu, Y. Chen, H. Luo, L. Wei, X. Zhang, J. Xin, J. Guo, Q. Wang, Z. Yuan, K. Zhang, W. Zhang, J. Yang, X. Zhong, S. Xia, L. Li, J. Cheng, E. Ma, P. He, S. S. Lee, Y. Wang, T. M. Uyeki, and W. Yang. 2008. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 3:e2985.